Alloga France
- A01 - Preparados estomatológicos
- DURAPHAT dental suspension 50 mg/ml
- A12 - Suplementos minerales
- KALEORID LP prolonged-release tablet 1 000 mg
- KALEORID LP prolonged-release tablet 600 mg
- C01 - Terapia cardíaca
- TRINIPATCH transdermal patch 10 mg/24 h
- TRINIPATCH transdermal patch 15 mg/24 h
- TRINIPATCH transdermal patch 5 mg/24 h
- C03 - Diuréticos
- BURINEX solution for injection 2 mg/4 ml
- BURINEX tablet 1 mg
- BURINEX tablet 5 mg
- C05 - Vasoprotectores
- DELIPROCT rectal ointment
- DELIPROCT suppository
- ULTRAPROCT rectal ointment
- ULTRAPROCT suppository
- D01 - Antifúngicos para uso dermatológico
- FONX cream 1%
- LAMISIL cream 1%
- LAMISIL cutaneous spray, solution 1%
- LAMISILATE cream 1%
- LAMISILATE MONODOSE cutaneous solution 1%
- LAMISILDERMGEL gel 1%
- PEVARYL cream 1%
- PEVARYL cutaneous emulsion 1%
- PEVARYL cutaneous powder 1%
- PEVARYL cutaneous spray, solution 1%
- PEVISONE cream
- D06 - Antibióticos y quimioterápicos para uso dermatológico
- CONDYLINE cutaneous solution 0.5%
- G01 - Antiinfecciosos y antisépticos ginecológicos
- GYNO PEVARYL pessary 150 mg
- H04 - Hormonas pancreáticas
- BAQSIMI EN RECIPIENT UNIDOSE nasal powder 3 mg
- J01 - Antibacterianos para uso sistémico
- SELEXID film-coated tablet 200 mg
- L01 - Antineoplásicos
- KIMMTRAK concentrate for solution for infusion 100 µg/0.5 ml
- L04 - Inmunosupresores
- EPYSQLI concentrate for solution for infusion 300 mg